Swiss skincare specialist Galderma has announced two-year data from a new interim analysis of a long-term extension study ...

As Denmark presses ahead with a major health reform, a coalition of rare disease advocates and clinicians is urging the ...

French pharma major Sanofi (Euronext: SAN) has started early global shipments of its monoclonal antibody Beyfortus ...

Knight will have the exclusive rights to distribute, promote, market and sell the products in Canada, and said it will begin ...

The Russian pharmaceutical market, valued at around $41 billion, continues to be a magnet for Indian pharmaceutical companies ...

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) and French pharma major Sanofi (Euronext: SAN) on Saturday presented ...

The European Council of Minister last week said it is ready to begin negotiations with the European Parliament, having agreed ...

US biotech PureTech Health (Nasdaq: PRTC) is positioning its lead candidate LYT-100 as a potential disruptor in the treatment of idiopathic pulmonary fibrosis (IPF), a rare lung condition long ...

Sanofi announced it is punting more than $9 billion to acquire Blueprint Medicines and its Ayvakit, BLU-808 and immunology ...

US drugmaker Vertex Pharmaceuticals (Nasdaq: VRTX) has announced data across multiple studies demonstrating positive clinical ...

Genetic testing company 23andMe is preparing for a renewed auction of its assets after a federal judge agreed to reopen the ...

In Latin America, the average percentage of the public budget for health is 12.75%, half of what is allocated by the 38 ...